2m 2m 2m 2m 2m 2m 2m
ERNEXA THERAPE (ERNA)
NASDAQ
$6.15-$0.03 (-0.52%)
Price as of Jun 23, 2026 8:00 PM EDT- $6.9MMarket Cap
- -87.52%1-Year Change
- BiotechnologyIndustry
ERNEXA THERAPE (ERNA)
$6.15-$0.03 (-0.52%)
ERNA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $6.18 | ||
Change | +$0.29 (+4.92%) | ||
Open | $5.82 | ||
High | $6.50 | ||
Low | $5.66 | ||
Previous Close | $5.89 | ||
Volume | 32,349 | ||
30-Day Average Volume | 63,454 | ||
1-Week Change | 1.31% | ||
1-Month Change | -48.46% | ||
1-Year Change | -87.52% | ||
3-Year Change | -99.26% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 1.2M | ||
Total Assets | $10.5M | ||
Market Cap | $6.9M | ||
Enterprise Value | -$630,299.00 | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | -$2.3M | ||
EBIT | -$40,000.00 | ||
EBITDA | -$32,000.00 | ||
Net Working Capital | $6.5M | ||
EPS | -$173.75 | ||
Enterprise Value/EBITDA | 20 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -0 | ||
PEG | N/A | ||
Price/Free Cash Flow | -3 | ||
Price/Operating Cash Flow | -3 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 25 | ||
Last Split Date | 05/04/2026 | ||
Earnings & Revenue